Most reproductive endocrinologists recommend not moving embryos until the implications of abortion regulations on in-vitro fertilization are more clear, Robert Hunter, MD, told one of his patients at the fertlity clinic he runs in Louisville, Ky.
Lora Shahine, MD, a reproductive endocrinologist at Seattle-based Pacific NW Fertility, told The 19th every single one of her patients has had similar questions, and she is also fielding requests from out-of-state patients. While she wants to help every patient, she said it’s a matter of logistics.
“We have to get together as a clinic and think, ‘How many of these patients can we accommodate?'” Dr. Shahine said. “The more outside of the state we are accommodating, the less people here in Seattle who want our care are going to be able to get our care. How do we balance that?”
Stephanie Gustin, MD, medical director at the Heartland Center for Reproductive Medicine in Omaha, Neb., told The 19th she’s been in touch with cryopreservation companies, who told her they intend to transport embryos if legislation limits physicians’ handling abilities.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
